CNS5:Medulloblastoma, WNT-activated: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Lisa Lansdon, PhD, Children's Mercy Hospital, Kansas City | Lisa Lansdon, PhD, Children's Mercy Hospital, Kansas City | ||
Midhat Farooqi, MD, Children's Mercy Hospital, Kansas City | Midhat Farooqi, MD, Children's Mercy Hospital, Kansas City | ||
__TOC__ | |||
==Cancer Category/Type== | ==Cancer Category/Type== | ||